Project Number 4UH3TR000967-02 Agency/Funding Organization NCATS Funding Year 2014 View Full Project Details for FYN INHIBITION BY AZD0530 FOR ALZHEIMERS DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator STRITTMATTER, STEPHEN M Principal Investigator First Name STEPHEN Principal Investigator Last Name STRITTMATTER Awardee Organization YALE UNIVERSITY Awardee State Connecticut Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-TR-12-004: LIMITED COMPETITION FOR NIH-INDUSTRY PILOT PROGRAM: DISCOVERING NEW THERAPEUTIC USES FOR EXISTING MOLECULES (UH2/UH3) FY Overall Cost $5,907,539 Funding Organization Agency/Funding Organization NCATS Funding Organization Country United States Program Official COLVIS, CHRISTINE Related Resources Clinical Trial A Phase IIa Multi-Center Study of 18F-FDG PET; Safety; and Tolerability of AZD0530 in Mild Alzheimer's Disease
